Pharmacotherapy of neuropathic pain

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 5, Issue 4, 2005, Pages 134-137

  Allen, Stephen ^a  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27244450103     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mki036     Document Type: Article

References (10)

1. Chapman C, Gavrin J. Suffering the contributions of persistent pain. Lancet 1999; 353: 2233-7
2. Woolf CJ, Mannion RJ. Neuropathic pain: Aetiology, symptoms, mechanisms and management. Lancet 1999; 353: 1959-64
3. Chong MS, Baiwa ZH. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage 2003; 25: S4-S11
4. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60: 1524-34
5. Sindrup S, Jensen T. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999; 83: 389-400
6. Bennett M. The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92: 147-57
7. Jensen TS. Anticonvulsants in neuropathic pain: Rationale and clinical evidence. Eur J Pain 2002; 6: 61-8
8. Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep in patients with post-herpetic neuralgia: Results of a randomized, placebo-controlled clinical trial. Pain 2004; 109: 26-35
9. Rowbotham MC. The debate over opioids and neuropathic pain. In: Kalso E, McQuay HJ, Wiesenfeld-Hallin Z, eds. Opioid Sensitivity of Chronic Noncancer Pain. Progress in Pain Research and Management, Volume 14. Seattle: IASP Press; 1999; 307-17.
10. Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind randomized, placebo controlled study on 160 patients. Mult Scler 2004; 10: 434-41